Daniël J. Vis
0009-0003-9522-5535
Publication & Citation Trends
Publications
114 total
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
Cited by 11
Semantic Scholar
A pan-cancer screen identifies drug combination benefit in cancer cell lines at the individual and population level. OA
Cited by 6
Semantic Scholar
Somatostatin receptor 1 (SSTR1) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic castration-resistant prostate cancer (mCRPC).
Cited by 0
Semantic Scholar
Platinum-based chemotherapy induces opposing effects on immunotherapy response-related spatial and stromal biomarkers in the bladder cancer microenvironment.
Cited by 4
Semantic Scholar
Clinical efficacy and biomarker analysis of pre-operative ipilimumab plus nivolumab in stage III urothelial cancer: The NABUCCO trial update.
Cited by 1
Semantic Scholar
Abstract 2488: The penile cancer tumor microenvironment and immunotherapy response: Results from the PERICLES trial
Cited by 0
Semantic Scholar
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]. OA
Cited by 1
Semantic Scholar
Research Topics
Bladder and Urothelial Cancer Treatments
(36)
Cancer Immunotherapy and Biomarkers
(26)
Cancer Genomics and Diagnostics
(20)
Bioinformatics and Genomic Networks
(14)
Urinary and Genital Oncology Studies
(13)
Affiliations
Leiden University
Netherlands Institute for Neuroscience
George Mason University
Utrecht University
Dutch Cancer Society